LTZ Therapeutics

📍 Redwood City, United States🗓 Founded 2022👥 35 employees💰 Last funded May 2025
Biotechnology Research🌐 ltztherapeutics.com
Website LinkedIn
LTZ Therapeutics is an immunotherapy-focused global biotech company pursuing innovative therapies in oncology and autoimmune diseases. Pioneering a novel myeloid engager platform that is guided by reverse translational science, emerging disease biology, and leveraging the power of myeloid cell subsets, particularly macrophages, which offer tremendous potential as an effective therapy to improve the lives of patients with the bold aim to one day eliminate cancer.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Hong Kong SAR
1
Frequently asked questions
Who invested in LTZ Therapeutics?
LTZ Therapeutics has 1 investors on record on gritt.io, 1 mid-stage.
When did LTZ Therapeutics last raise funding?
The most recent investment in LTZ Therapeutics recorded on gritt.io was in May 2025.
When was LTZ Therapeutics founded?
LTZ Therapeutics was founded in 2022.
What industry is LTZ Therapeutics in?
LTZ Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is LTZ Therapeutics based?
LTZ Therapeutics is headquartered in Redwood City, United States.